Meihua International Medical Technologies Announces Extraordinary General Meeting

Meihua International Medical Technologies Co., Ltd. has announced an Extraordinary General Meeting (EGM) to be held on November 3, 2025. The meeting will address several key proposals, including a share consolidation, an increase in authorized share capital, and amendments to the company's memorandum and articles of association. The share consolidation aims to regain compliance with Nasdaq's minimum bid price requirement by consolidating every 100 ordinary and preferred shares into one share each. The company also proposes to increase its authorized share capital from USD50,000 to USD500,000,000 and to amend its share capital structure by creating new classes of shares. Additionally, the company seeks approval for its 2025 Equity Incentive Plan, which will reserve 83,856 Class A Ordinary Shares for issuance. The board unanimously recommends voting in favor of all proposals.